SENTINEL aims at developing a minimally invasive and biocompatible implantable biosensor to be used in the early tumor surveillance in post-operative prostate cancer patients. Placed under the user’s skin, the sensor allows optical readout of the patient’s disease state using a portable probe, which acquired signals are then analysed using machine learning algorithms to infer the disease status.
The SENTINEL consortium is led by Stemmatters with co-promoters from the North region of Portugal (INL, ICVS and 2CA) and an international partner (University of Texas at Austin).
The funding of SENTINEL projects is funded by UT Austin Portugal Program.
Company Details
- Founded
- -
- Address
- Guimarães, Pt
- Industry
- Biotechnology
- Website
- https://www.project-sentinel.co/
- HQ
- Guimarães
Project Sentinel Questions
Project Sentinel's website is https://www.project-sentinel.co/
Project Sentinel's LinkedIn profile is https://www.linkedin.com/company/sentinel-project
Project Sentinel's industry is
Biotechnology
Project Sentinel's top competitors are
Complement Pharma,
Concept,
Oncostellae,
Paralab Bio Sa,
Somaserve,
Protarget Study,
Nederlandse Biotechnologie Vereniging,
Ohmx.bio,
Intellidigest,
Ig Therapeutics.
Project Sentinel's categories are Biotechnology
Project Sentinel's founding year is 2020
